CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 

United Cannabis's Total Debt to Equity

CNAB's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to debt repayement of -12.62% United Cannabis improved Total Debt to Equity in second quarter 2019 to 0.01, a new company low.

Within Major Pharmaceutical Preparations industry in the second quarter 2019, 15 other companies have achieved lower Total Debt to Equity than United Cannabis in the II Quarter 2019. While Total Debt to Equity total ranking has deteriorated compared to the first quarter 2019 from 88 to 108 .

Explain Debt to Equity Ratio?
What is the structure of CNAB´s Total Debt?
How valuable is the CNAB´s Equity?


CNAB Total Debt to Equity (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Equity Change -17.5 % -7.44 % 24.43 % 65.84 % 3129.27 %
Y / Y Total Debt Change -52.6 % 56.67 % 23.85 % - -
Total Debt to Equity MRQ 0.01 0.01 0.01 0.01 0.02
CNAB's Total Ranking # 108 # 88 # 170 # 104 # 126
Seq. Equity Change -8.35 % -22.81 % -14.63 % 36.61 % 2.82 %
Seq. Total Debt Change -12.62 % -11.21 % -10.08 % -32.06 % 188.81 %



Total Debt to Equity second quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 31
Overall Market # 108


Total Debt to Equity Statistics
High Average Low
5.62 0.8 0.01
(Dec 31 2013)   (Mar 31 2018)




Financial Statements
United Cannabis's Equity $ 5 Millions Visit CNAB's Balance sheet
United Cannabis's Total Debt $ 0 Millions Visit CNAB's Balance sheet
Source of CNAB's Sales Visit CNAB's Sales by Geography


Cumulative United Cannabis's Total Debt to Equity

CNAB's Total Debt to Equity for the trailling 12 Months

CNAB Total Debt to Equity

(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Equity TTM Growth -17.5 % -7.44 % 24.43 % 65.84 % 3129.27 %
Y / Y Total Debt TTM Growth -52.6 % 56.67 % 23.85 % - -
Total Debt to Equity TTM 0.01 0.01 0.01 0.01 0.01
Total Ranking TTM # 21 # 408 # 419 # 343 # 340
Seq. Equity TTM Growth -8.35 % -22.81 % -14.63 % 36.61 % 2.82 %
Seq. Total Debt TTM Growth -12.62 % -11.21 % -10.08 % -32.06 % 188.81 %


On the trailing twelve months basis Due to debt repayement of -12.62% United Cannabis has not changed Total Debt to Equity in the 12 months ending in II Quarter 2019 to 0.01, below the company's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 4, during the past 12 months, other companies have achieved lower Total Debt to Equity than United Cannabis. While Total Debt to Equity total ranking has improved so far to 21, from total ranking in previous 12 month period at 408.

Explain Debt to Equity Ratio?
What is the structure of CNAB´s Total Debt?
How valuable is the CNAB´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 10
Within the Market # 21


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.02 0.01 0
(Sep 30 2019)   (Mar 31 2018)




Companies with similar Total Debt to Equity in the quarter ending Jun 30 2019, within Major Pharmaceutical Preparations Industry Total Debt to EquityJun 30 2019 MRQ Total DebtJun 30 2019 MRQ Equity
Zai Lab Limited  0.02 $ 6.450  Millions$ 294.660  Millions
Sonoma Pharmaceuticals Inc   0.02 $ 0.211  Millions$ 11.504  Millions
Arvinas Inc   0.02 $ 2.071  Millions$ 116.505  Millions
Alnylam Pharmaceuticals Inc   0.02 $ 30.000  Millions$ 1,757.195  Millions
Sinovac Biotech Ltd  0.02 $ 5.934  Millions$ 352.195  Millions
Casi Pharmaceuticals inc   0.02 $ 1.500  Millions$ 89.038  Millions
Tyme Technologies Inc.  0.02 $ 0.195  Millions$ 11.986  Millions
Theratechnologies Inc   0.01 $ 0.266  Millions$ 24.834  Millions
Anaptysbio Inc   0.01 $ 4.781  Millions$ 448.421  Millions
Chembio Diagnostics Inc   0.01 $ 0.287  Millions$ 27.938  Millions
Athenex Inc   0.01 $ 1.685  Millions$ 167.207  Millions
United Cannabis Corp  0.01 $ 0.045  Millions$ 5.166  Millions
Tempest Therapeutics Inc   0.01 $ 0.477  Millions$ 55.025  Millions
Citius Pharmaceuticals Inc   0.01 $ 0.173  Millions$ 21.507  Millions
Affimed N v   0.01 $ 0.311  Millions$ 43.307  Millions
Actinium Pharmaceuticals Inc   0.01 $ 0.101  Millions$ 15.700  Millions
Galmed Pharmaceuticals Ltd   0.01 $ 0.442  Millions$ 69.853  Millions
Pfenex Inc   0.01 $ 0.305  Millions$ 51.812  Millions
Rezolute Inc   0.01 $ 0.010  Millions$ 1.752  Millions
Vistagen Therapeutics Inc   0.01 $ 0.009  Millions$ 1.626  Millions
Celyad Oncology Sa  0.01 $ 0.256  Millions$ 51.093  Millions
Forty Seven Inc 0.00 $ 0.361  Millions$ 91.484  Millions
Oncosec Medical Incorporated 0.00 $ 0.084  Millions$ 24.279  Millions
Palatin Technologies Inc 0.00 $ 0.333  Millions$ 100.549  Millions
Spero Therapeutics Inc 0.00 $ 0.293  Millions$ 109.669  Millions
Galapagos Nv 0.00 $ 7.828  Millions$ 3,220.737  Millions
Corbus Pharmaceuticals Holdings Inc 0.00 $ 0.099  Millions$ 47.374  Millions
Cv Sciences Inc 0.00 $ 0.069  Millions$ 34.288  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com